DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

INO-1001

Generic Name: INO-1001

Drug Type: Small Molecule

Chemical Formula: C_₂₄H_₂₉N_₃O_₇S_₂

CAS Number: 501364-91-6

Unique Ingredient Identifier: 55E08EN074

Overview

No overview information available.

Background

No background information available.

Indication

Investigated for use/treatment in brain cancer, cardiovascular disorders, and myocardial infarction.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study of Intravenous INO-1001 Plus Oral Temozolomide to Evaluate Tolerability, Safety, and Pharmacokinetics in Patients With Melanoma

Phase 1

Terminated

Posted: 2006/01/06

Sponsor:Genentech, Inc.

A Study of INO-1001, an Intravenous PARP (Poly [ADP Ribose] Polymerase) Inhibitor in Acute Heart Attack Patients Undergoing Primary Percutaneous Coronary Intervention

Phase 2

Completed

Posted: 2006/01/04

Sponsor:

Inotek Pharmaceutica...

A Trial of INO-1001 in Patients Undergoing Heart Surgery That Involves Heart-lung Bypass

Phase 2

Terminated

Posted: 2005/12/30

Sponsor:

Inotek Pharmaceutica...

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy